(Seoul = Yonhap News) Reporter Kim Ji-yeon = Digital healthcare company MEZOO announced on the 18th that its public offering subscription for retail investors, held from the 16th to the 17th, recorded a competition rate of 2,428.25 to 1.
The total number of subscriptions reached 414,962, with the subscription margin (deposits) totaling 8.8182 trillion KRW.
Founded by a research team holding Ph.D.s in biomedical engineering from Yonsei University's Wonju Campus, MEZOO is a digital healthcare company that has developed and commercialized a platform designed to bridge the monitoring gap both inside and outside of hospitals, utilizing biosignal measurement and analysis technology.
In particular, through its mobile remote patient monitoring technology that accommodates patient mobility and daily environments, the company has overcome the limitations of traditional hospital-centric monitoring and established a platform capable of expanding into the everyday lives of patients.
With the funds secured from this public offering, MEZOO plans to fully launch its global business expansion and accelerate the advancement of its artificial intelligence (AI)-based technologies.
Specifically, the company's strategy is to accelerate its transformation into a global medical data-based platform enterprise by promoting the following:
Establishing a distribution network focused on the North American and European markets
Expanding local sales, marketing, and joint research
Advancing AI-based predictive and diagnostic technologies
